We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$49.7B
AUM Growth
+$4.78B
Cap. Flow
+$1.33B
Cap. Flow %
2.67%
Top 10 Hldgs %
15.14%
Holding
3,458
New
199
Increased
1,346
Reduced
1,583
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 9.83%
2 Financials 6.76%
3 Healthcare 6.38%
4 Industrials 4.74%
5 Consumer Discretionary 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
3101
CALL
DELISTED
Activision Blizzard
ATVI
$35.5K ﹤0.01%
+20,900
New +$1.55M
JOAN
3102
DELISTED
JOANN, Inc. Common Stock
JOAN
$35.5K ﹤0.01%
12,443
+1,000
+9% +$4.72K
SFIX
3103
Stitch Fix
SFIX
$474M
$35K ﹤0.01%
11,251
+767
+7% +$2.87K
PLUG icon
3104
CALL
Plug Power
PLUG
$3.23B
$35K ﹤0.01%
+31,700
New +$505K
CODX
3105
Co-Diagnostics
CODX
$5.6M
$34.9K ﹤0.01%
461
-64
-12% -$5.99K
AGEN
3106
Agenus
AGEN
$320M
$34.7K ﹤0.01%
737
-2
-0.3% -$102
WRAP icon
3107
Wrap Technologies
WRAP
$98.1M
$34.3K ﹤0.01%
20,295
-142
-0.7% -$258
BRDS
3108
DELISTED
Bird Global, Inc.
BRDS
$34.1K ﹤0.01%
7,571
ASLE icon
3109
CALL
AerSale
ASLE
$269M
$33.8K ﹤0.01%
+12,500
New +$217K
NVTA
3110
DELISTED
Invitae Corporation
NVTA
$33.6K ﹤0.01%
18,075
+1,306
+8% +$3.19K
RVLP
3111
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$33.1K ﹤0.01%
29,519
FLYW icon
3112
CALL
Flywire
FLYW
$2.12B
$32.5K ﹤0.01%
10,500
KG
3113
Kestrel Group
KG
$68.3M
$32.3K ﹤0.01%
+765
New +$32.6K
ALPP
3114
DELISTED
Alpine 4 Holdings Inc
ALPP
$32.3K ﹤0.01%
7,631
-593
-7% -$2.92K
GLD icon
3115
CALL
SPDR Gold Trust
GLD
$144B
$32.2K ﹤0.01%
14,900
-600
-4% -$96.6K
OSCR icon
3116
Oscar Health
OSCR
$9.07B
$32.1K ﹤0.01%
13,034
-700
-5% -$2.19K
BARK icon
3117
BARK
BARK
$99.8M
$32K ﹤0.01%
1,073
+380
+55% +$12.6K
GAIA icon
3118
Gaia
GAIA
$30.8M
$31.6K ﹤0.01%
13,275
REFR icon
3119
Research Frontiers
REFR
$16.6M
$30.4K ﹤0.01%
15,935
HRTX icon
3120
Heron Therapeutics
HRTX
$66M
$30.1K ﹤0.01%
12,025
-85
-0.7% -$274
ORIO
3121
Orion Digital Corp
ORIO
$20.2M
$29.8K ﹤0.01%
18,750
-4,429
-19% -$9.03K
VIEW
3122
DELISTED
View, Inc. Class A Common Stock
VIEW
$29.4K ﹤0.01%
507
-119
-19% -$8.7K
QCLS
3123
Q/C Technologies Inc
QCLS
$22.9M
$28.5K ﹤0.01%
8
PYPD icon
3124
PolyPid
PYPD
$90.7M
$28K ﹤0.01%
1,336
+209
+19% +$5.4K
OESX icon
3125
Orion Energy Systems
OESX
$85.1M
$26.9K ﹤0.01%
1,480

Similar funds

Raymond James Financial Services Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James Financial Services Advisors held 3,458 positions worth $49.7B, up 11% from $45B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James Financial Services Advisors's Q4 2022 filing shows 199 new, 1,346 increased, 1,583 reduced and 208 closed positions. Its largest new stake was Invesco BulletShares 2023 USD Emerging Markets Debt ETF: 288,687 shares worth $6.71M. The largest sale was Broadcom, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q4 2022 buy was Invesco BulletShares 2023 USD Emerging Markets Debt ETF: 288,687 shares worth $6.71M.
  • Raymond James Financial Services Advisors added most to Vanguard Morningstar Value ETF in Q4 2022, an estimated $130M increase.
  • Raymond James Financial Services Advisors's biggest Q4 2022 reduction was Broadcom, cutting an estimated $46.2M.
  • Raymond James Financial Services Advisors fully exited iShares iBonds Dec 2022 Term Corporate ETF in Q4 2022, selling an estimated $21.2M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 15% of its $49.7B portfolio in Q4 2022.
  • Raymond James Financial Services Advisors opened 199 new positions and closed 208 in Q4 2022.
  • Raymond James Financial Services Advisors's portfolio value rose 11% quarter-over-quarter to $49.7B.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.